Atlas Trials

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Clinical trial NCT00215943 · TERMINATED

Trial details

NCT number
NCT00215943
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2003-06-01
Primary completion
2012-08-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.